Cancers (May 2021)

Texture Analysis of Fractional Water Content Images Acquired during PET/MRI: Initial Evidence for an Association with Total Lesion Glycolysis, Survival and Gene Mutation Profile in Primary Colorectal Cancer

  • Balaji Ganeshan,
  • Kenneth Miles,
  • Asim Afaq,
  • Shonit Punwani,
  • Manuel Rodriguez,
  • Simon Wan,
  • Darren Walls,
  • Luke Hoy,
  • Saif Khan,
  • Raymond Endozo,
  • Robert Shortman,
  • John Hoath,
  • Aman Bhargava,
  • Matthew Hanson,
  • Daren Francis,
  • Tan Arulampalam,
  • Sanjay Dindyal,
  • Shih-Hsin Chen,
  • Tony Ng,
  • Ashley Groves

DOI
https://doi.org/10.3390/cancers13112715
Journal volume & issue
Vol. 13, no. 11
p. 2715

Abstract

Read online

To assess the capability of fractional water content (FWC) texture analysis (TA) to generate biologically relevant information from routine PET/MRI acquisitions for colorectal cancer (CRC) patients. Thirty consecutive primary CRC patients (mean age 63.9, range 42–83 years) prospectively underwent FDG-PET/MRI. FWC tumor parametric images generated from Dixon MR sequences underwent TA using commercially available research software (TexRAD). Data analysis comprised (1) identification of functional imaging correlates for texture features (TF) with low inter-observer variability (intraclass correlation coefficient: ICC > 0.75), (2) evaluation of prognostic performance for FWC-TF, and (3) correlation of prognostic imaging signatures with gene mutation (GM) profile. Of 32 FWC-TF with ICC > 0.75, 18 correlated with total lesion glycolysis (TLG, highest: rs = −0.547, p = 0.002). Using optimized cut-off values, five MR FWC-TF identified a good prognostic group with zero mortality (lowest: p = 0.017). For the most statistically significant prognostic marker, favorable prognosis was significantly associated with a higher number of GM per patient (medians: 7 vs. 1.5, p = 0.009). FWC-TA derived from routine PET/MRI Dixon acquisitions shows good inter-operator agreement, generates biological relevant information related to TLG, GM count, and provides prognostic information that can unlock new clinical applications for CRC patients.

Keywords